AI is pharma’s newest customer and channel. Winning both requires evolving the strategy and go-to-market model.
Bain’s comprehensive survey reveals global trends, but customer priorities in a transforming auto industry are split by ...
AI-enabled procurement models can deliver returns of up to five times the initial investment as well as productivity gains of ...
If AI lets your engineers write code 5 to 10 times faster, what happens to everything that runs after the code ships?
Cutting costs and waiting for recovery won’t work in a structural reset. Winners will boldly pursue a clear advantage.
Generative AI has become a fully embedded habit for billions worldwide. In the US, 73% of the consumers we surveyed in April said they were using generative AI applications and tools in their personal ...
Survey data shows what revenue and margin winners do differently—and how to build a similar system.
India’s social sector funding is scaling quickly but continues to lag estimated demand. Total funding grew at a 13% CAGR between FY20 and FY25 to roughly INR 27 lakh crore ($310 billion) and is ...
The generative artificial intelligence (AI) transformation is well underway in pharma. And pharma companies have high confidence in its value: Already, 40% of executives say that they are baking ...
With average holding periods stretching toward seven years and buyout funds sitting on approximately 32,000 unsold companies worth $3.8 trillion, boosting exit momentum is at the top of every fund ...
While all revenue and profits ultimately come from customers, most companies place more emphasis on product P&Ls and functional budgets than on customer value. We pioneered the concept of Customer ...
e-Conomy SEA is a multi-year research programme launched by Google and Temasek in 2016. Bain & Company joined the programme as lead research partner in 2019. The research leverages Temasek insights, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results